OCUGEN, INC. Preferred Stock, Shares Outstanding
OCUGEN, INC. (OCGN) had Preferred Stock, Shares Outstanding of 0 shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2024-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding | Preferred Stock, Shares Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-06 | |
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-08-06 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-09 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-04 | |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-08 | |
| 2023-12-31 | 54.74K shares 10-K · filed 2025-03-05 | |
| 2020-12-31 | 7.00 shares 10-K · filed 2021-03-19 | |
| 2020-09-30 | 7.00 shares 10-Q · filed 2020-11-06 | |
| 2020-06-30 | 7.00 shares 10-Q · filed 2020-08-14 | |
| 2020-03-31 | 7.00 shares 10-Q · filed 2020-05-08 | |
| 2019-12-31 | 7.00 shares 10-K · filed 2021-03-19 | |
| 2019-09-30 | 7.00 shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 400.49 shares 10-Q · filed 2019-08-09 | |
| 2019-03-31 | 400.00 shares 10-Q · filed 2019-05-15 | |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-27 | 400.00 shares 10-Q · filed 2019-05-15 |
| 2016-09-30 | 24.16K shares 10-Q · filed 2016-11-10 | |
| 2015-12-31 | 0.00 shares 10-Q · filed 2016-11-10 | |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-12 | |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-14 | |
| 2014-12-31 | 0.00 shares 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |